Abstract
Liraglutide, the Synthetic Glucagon-like Peptide-1 Receptor Agonist, Improves Insulin Sensitivity of 3T3-L1 Adipocytes and Affects the Kinetics of Mitogenic and Inflammatory Kinases
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have